KMDA
Kamada Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$7.61
−1.93%Forward multiples
Based on analyst estimates
- P/E forward
- 16.54x
- P/E 2026E
- 16.05x
- P/E 2027E
- 13.29x
- P/E 2028E
- 11.85x
- P/S forward
- 1.98x
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.87x
- PEG TTM
- 1.00x
- Price / book
- 1.63x
- Price / sales
- 2.29x
- Price / cash flow
- 12.20x
Enterprise value
- Enterprise value
- $380.8M
- EV / sales
- 1.99x
- EV / EBITDA
- 9.07x
- EV / EBIT
- 13.68x
- Market cap
- $439.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026